Benzinga's Top Upgrades, Downgrades For January 2, 2018 - Allstate (NYSE:ALL), Abbott Laboratories (NYSE:ABT)

Analysts at JP Morgan upgraded Stryker Corporation SYK from Neutral to Overweight. Stryker shares rose 1.39 percent to $157.00 in pre-market trading.
Wells Fargo upgraded Illumina, Inc. ILMN from Market Perform to Outperform. Illumina shares rose 1.61 percent to $222.00 in pre-market trading.
Analysts at Morgan Stanley upgraded Abbott Laboratories ABT from Equal-Weight to Overweight. Abbott shares gained 2.51 percent to $58.50 in pre-market trading.
Macquarie upgraded Netflix, Inc. NFLX from Neutral to Outperform. Netflix shares gained 1.57 percent to $194.98 in pre-market trading.
Analysts at Wells Fargo upgraded Lennar Corporation LEN from Market Perform to Outperform. Lennar shares fell 0.89 percent to close at $63.24 on Friday.
Analysts at Baird upgraded L Brands Inc LB from Neutral to Outperform. L Brands shares rose 1.08 percent to $60.87 in pre-market trading.
Macquarie upgraded Walt Disney Co DIS from Neutral to Outperform. Disney shares rose 0.73 percent to $108.30 in pre-market trading.
Longbow Research upgraded Timken Co TKR from Neutral to Buy. Timken shares rose 0.20 percent to close at $49.15 on Friday.
Analysts at RBC Capital upgraded Incyte Corporation INCY from Sector Perform to Outperform. Incyte shares rose 2.41 percent to $96.99 in pre-market trading.
Jefferies upgraded Genesco Inc. GCO from Hold to Buy. Genesco shares closed at $32.50 on Friday.

Analysts at JP Morgan downgraded Johnson & Johnson JNJ from Overweight to Neutral. Johnson & Johnson shares fell 0.23 percent to $139.40 in pre-market trading.
Jefferies downgraded Planet Fitness Inc PLNT from Buy to Hold. Planet Fitness shares fell 3.03 percent to $33.58 in pre-market trading.
Keefe Bruyette & Woods downgraded Allstate Corp ALL from Market Perform to Underperform. Allstate shares fell 0.18 percent to close at $104.71 on Friday.
Analysts at Leerink Swann downgraded Sucampo Pharmaceuticals SCMP from Outperform to Market Perform. Sucampo Pharmaceuticals shares fell 0.18 percent to close at $104.71 on Friday.
RBC Capital downgraded Merus NV MRUS from Outperform to Sector Perform. Merus climbed 13.15 percent to close at $18.84 on Friday.
Raymond James downgraded Cabot Oil & Gas Corporation COG from Outperform to Underperform. Cabot Oil shares fell 1.75 percent to $28.10 in pre-market trading.
Citigroup downgraded Lululemon Athletica inc. LULU from Buy to Neutral. Lululemon shares closed at $78.59 on Friday.
Macquarie downgraded Viacom, Inc. VIAB from Neutral to Underperform. Viacom shares dropped 0.78 percent to $30.57 in pre-market trading.
Morgan Stanley downgraded Hill-Rom Holdings, Inc. HRC from Overweight to Equal-Weight. Hill-Rom shares fell 1.16 percent to close at $84.29 on Friday.
Guggenheim downgraded PG&E Corporation PCG from Neutral to Sell. PG&E shares rose 0.02 percent to close at $44.83 on Friday.

JP Morgan initiated coverage on Quanterix Corp QTRX with an Overweight rating. The price target for Quanterix is set to $24. Quanterix shares closed at $21.47 on Friday.
Evercore ISI Group initiated coverage on Denali Therapeutics Inc. DNLI with an Outperform rating. The price target for Denali Therapeutics is set to $23. Denali Therapeutics shares closed at $15.64 on Friday.
BMO Capital initiated coverage on Delphi Technologies PLC DLPH with an Outperform rating. The price target for Delphi Technologies is set to $73. Delphi Technologies shares closed at $52.47 on Friday.
Analysts at Cowen & Co. initiated coverage on Odonate Therapeutics Inc ODT with an Outperform rating. Odonate Therapeutics shares closed at $25.00 on Friday.
DA Davidson initiated coverage on Luther Burbank Corp LBC with a Neutral rating. The price target for Luther Burbank is set to $13. Luther Burbank shares closed at $12.04 on Friday.
Analysts at Jefferies initiated coverage on Curo Group Holdings Corp CURO with a Buy rating. The price target for Curo Group is set to $19. Curo Group shares closed at $14.08 on Friday.
Analysts at BTIG Research initiated coverage on Quanterix Corp QTRX with a Buy rating. The price target for Quanterix is set to $26. Quanterix shares closed at $21.47 on Friday.